Veeva Advances Digital Asset Management for Life Sciences with Vault PromoMats Brand Portal
Today at Veeva European Commercial & Medical Summit , one of the largest life sciences events for commercial and medical affairs professionals in Europe, Veeva Systems (NYSE:VEEV) announced a new digital asset management capability that makes it simple for brand managers to create portals that organize and showcase content within Veeva Vault PromoMats . With Veeva Vault PromoMats Brand Portal , marketing teams can share digital assets and campaigns in one place so employees, affiliates, and agencies can easily find and leverage existing content.
“Veeva is expanding the digital asset management capabilities in Vault PromoMats to help organizations drive greater reuse of the growing volume of content they’re creating,” said David Bennett, Veeva vice president of strategy, commercial content in Europe. “Vault PromoMats is the first and only application that combines best-in-class digital asset management and medical, legal, regulatory review capabilities in a single solution tailored specifically for life sciences.”
While brand teams are creating more digital assets than ever, agencies, affiliates, and other marketing teams often lack visibility into the content that exists. This results in wasted effort as duplicate content is created, costing time and money.
Vault PromoMats Brand Portal provides a simple, intuitive interface to promote and organize digital content. Brand managers can curate and share approved campaigns and assets, direct others to content they should use, and make it easier for teams to search, browse, and access the assets they need – all in one place. Now brand managers can fully maximize their content investments and improve reuse by internal and external teams to drive greater consistency.
Veeva Vault PromoMats combines digital asset management with medical, legal, regulatory review to eliminate the need to move, duplicate, and manage content across multiple systems. This results in improved visibility and control throughout the digital supply chain. The new capability, Vault PromoMats Brand Portal, is planned for availability in December 2017.
In other news today, Veeva announced that four of the top 20 pharmaceutical companies have adopted Veeva Align across various regions to perform fast, accurate territory alignments. Veeva also announced Veeva CRM Engage Webinar , the first purpose-built application to manage compliant virtual events in the life sciences industry. Read the Veeva Align news and the Veeva CRM Engage Webinar news to learn more.
Veeva European Commercial & Medical Summit is one of the industry’s largest European events dedicated to commercial and medical solutions for life sciences. This year more than 800 life sciences professionals and industry experts will participate in the two-day conference to learn, connect, and share valuable insight on industry trends and best practices.
For more on Vault PromoMats Brand Portal, visit: veeva.com/eu/BrandPortal
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @Veeva_EU on Twitter: twitter.com/veeva_eu
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 550 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit www.veeva.com/eu .
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the company’s filing on Form 10-Q for the period ended 31 July, 2017. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov . Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
SES/TIMOR-TELECOM18.12.2017 08:57 | pressemeddelelse
Timor Telecom Enhances International Voice Connections in Timor-Leste Through SES Networks
STEEPER-ENERGY18.12.2017 08:02 | pressemeddelelse
Steeper Energy Announces EUR 50.6 M (DKK 377 M) Advanced Biofuel Project with Norwegian-Swedish joint venture Silva Green Fuel in Licensing Deal
YOKOGAWA-ELECTRIC18.12.2017 03:02 | pressemeddelelse
Yokogawa Develops N-IO Standard Field Enclosure and Control System Virtualization Platform
CELLTRION15.12.2017 23:15 | pressemeddelelse
Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar
TAKEDA15.12.2017 13:36 | pressemeddelelse
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
TWISPAY15.12.2017 13:23 | pressemeddelelse
Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum